Capital Fund Management S.A. Sage Therapeutics, Inc. Put Options Transaction History

Capital Fund Management S.A.

  • $36 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
SELL
$18.62 - $26.95 $310,954 - $450,065
-16,700 Reduced 29.61%
39,700 $743,000
Q4 2023

Feb 14, 2024
BUY
$17.1 - $22.26 $779,760 - $1.02 Million
45,600 Added 422.22%
56,400 $1.22 Million
Q3 2023

Nov 14, 2023
BUY
$16.75 - $48.98 $180,900 - $528,984
10,800 New
10,800 $222,000

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
46.4M
Call Options Held
847K
Put Options Held
188K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Capital Fund Management S.A. Portfolio

Follow Capital Fund Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email